THBS1 and peripheral arterial disease: Given the established anti-angiogenic property of TSP-1 and its dysregulation in diseases, it holds great value to design novel therapeutic strategies that aim to restore TSP-1 expression in tumors and limit its expression in PAD by regulating the biomolecules that control TSP-1 synthesis.